Though the legal market for CBD products has only existed in the United States for a few short years, they’ve already become dominant in the wellness space. The industry is bringing in billions on an annual basis, and products infused with CBD are bestsellers at many major department stores. However, many people still don’t know much about the cannabis compound, how it works, or what medical applications it has. Keep reading if you want to learn more about CBD and whether or not it can be helpful for individuals with Guillain-Barre syndrome.
What is CBD and how does it work?
CBD is short for cannabidiol, which is one of the many cannabinoids found in the cannabis plant. There are hundreds of different cannabinoids, all of which produce different effects. There are also other cannabis products that contain cannabinoids like CBD, including these 1000 mg delta 8 gummies. Delta-8 has become popular in recent years due to its similarity to another compound, delta-9 THC, which is what produces the signature high associated with other forms of cannabis. Users generally describe the experience as light, relaxing, and enjoyable.
Products like CBD and delta-8 were legalized through the passage of the 2018 Farm Bill, which permitted the sale of hemp and hemp extracts in the United States. However, since then, many states have independently moved to restrict the sale of certain CBD and delta-8 products. The legal landscape is constantly shifting when it comes to cannabis, so make sure you check your local laws before using them in your area. The fact that these hemp derivatives remain legal on a federal level should keep them fairly accessible.
If you’ve never used cannabis products like CBD or delta-8 before, you should consult your doctor before trying them for the first time. Your doctor can tell you how they may affect any health conditions you have or interact with prescription medications you’re currently taking.
Can CBD help Guillain-Barre syndrome?
Guillain-Barre syndrome is a rare neurological disorder that causes the immune system to attack the peripheral nervous system. This results in muscle weakness, paralysis, numbness, tingling, and in rare cases, it can affect respiratory function, causing an inability to breathe independently. There are two forms of Guillain Barre syndrome treatment that are designed to reduce the severity of the illness and promote faster recovery time: immunoglobulin therapy and plasmapheresis. Rehabilitation services, like physical therapy, are also often necessary and beneficial for individuals with GBS.
When it comes to the medical impact of CBD products, there is a lot of research underway aimed at identifying potential use cases. Many of these studies are still in their early stages, so we’ll need to see what data emerges before it can be used as a treatment for specific conditions. There has been progressed in recent years, with the FDA approving their first prescription drug containing cannabidiol as an active ingredient. Epidiolex was approved to treat seizures caused by rare forms of epilepsy like Dravet syndrome and Lennox-Gastaut syndrome. Those in the community are hopeful that this is the only beginning, and more health-related applications for CBD will be uncovered soon.
There’s clearly a lot we still need to learn about CBD before it can be used as a treatment for many conditions, but the cannabinoid does seem to have potential based on early research. When it comes to Guillain-Barre syndrome, the primary forms of treatment remain immunoglobulin therapy and plasmapheresis, with supplementary rehabilitation services as needed. In the future, it’s likely that clinical studies will teach us more about how CBD can be used and who can benefit the most from it. For now, it can still be a useful part of a daily wellness routine for millions of people all over the world.